<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04510142</url>
  </required_header>
  <id_info>
    <org_study_id>5870</org_study_id>
    <nct_id>NCT04510142</nct_id>
  </id_info>
  <brief_title>Questionnaire Follow=up Study Sonia 2</brief_title>
  <acronym>QSonia</acronym>
  <official_title>Questionnaire Follow=up Study Sonia 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Liverpool University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Liverpool University Hospitals NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Survey of health of patients completing SONIA 2 study: A cross-sectional analysis by&#xD;
      questionnaire&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Liverpool site will post the once only, short questionnaire (in the correct language&#xD;
      using translated documents as appropriate) to the address of those patients who completed&#xD;
      SONIA 2. Hospital approved translation services will be used. A return-addressed stamped&#xD;
      envelope for ease of return will also be provided. Those who received nitisinone will be sent&#xD;
      the nitisinone-administration questionnaire and those who did not receive nitisinone will be&#xD;
      sent a no-nitisinone questionnaire&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 19, 2019</start_date>
  <completion_date type="Anticipated">April 19, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 19, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>to collect information on their health status since completing participation in SONIA 2</measure>
    <time_frame>12 months</time_frame>
    <description>All of the SONIA 2 completed questionnaire data collection is completed by 2 Sept 2020</description>
  </primary_outcome>
  <enrollment type="Anticipated">3</enrollment>
  <condition>Alkaptonuria</condition>
  <condition>Homogentisic Acid</condition>
  <condition>Homogentisate Dioxygenase</condition>
  <condition>Alkaptonuria Severity Score Index</condition>
  <eligibility>
    <study_pop>
      <textblock>
        cross-sectional cohort who completed SONIA 2 Study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Documented diagnosis of AKU. Age â‰¥16 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Not completed SONIA 2 study for the full 4-year duration.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Royal Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <zip>L7 8XP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prof L Ranganath</last_name>
      <phone>01517064256</phone>
      <email>lrang@liv.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Helen Bygott</last_name>
      <phone>01517064289</phone>
      <email>helen.bygott@rlbuht.nhs.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 10, 2020</study_first_submitted>
  <study_first_submitted_qc>August 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 12, 2020</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Liverpool University Hospitals NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Emily Luangrath</investigator_full_name>
    <investigator_title>Research Nurse</investigator_title>
  </responsible_party>
  <keyword>Royal Liverpool University Hospital</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alkaptonuria</mesh_term>
    <mesh_term>Ochronosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

